"10.1371_journal.pone.0081969","plos one","2013-12-04T00:00:00Z","Caroline E Zetterstr√∂m; Jenny Hasselgren; Olli Salin; Rohan A Davis; Ronald J Quinn; Charlotta Sundin; Mikael Elofsson","Ume√• Centre for Microbial Research, Laboratories for Infection Medicine Sweden, Department of Chemistry, Ume√• University, Ume√•, Sweden; Creative Antibiotics Sweden AB, Ume√•, Sweden; Department of Clinical Microbiology, Ume√• University, Ume√•, Sweden; Eskitis Institute, Griffith University, Brisbane, Australia; Laboratories for Chemical Biology Ume√•, Department of Chemistry, Ume√• University, Ume√•, Sweden","Conceived and designed the experiments: CEZ RJQ CS ME. Performed the experiments: CEZ JH OS RAD. Analyzed the data: CEZ RAD RJQ CS ME. Contributed reagents/materials/analysis tools: RJQ RAD. Wrote the manuscript: CEZ CS ME.","Part of the work was carried out at the company Creative Antibiotics AB that was declared bankrupt in June 2013.  The project and results generated by the company are now the property of Griffith University.  Griffith University has filed patent applications including (-)-hopephenol and its applications (New use, application numbers EP13159499.6 and US61/789,815).  This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Caroline E Zetterstr√∂m","CEZ√",7,TRUE,4,4,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
